Shopping Cart
Remove All
Your shopping cart is currently empty
ROCK2 inhibitor is a chemical compound associated with the therapeutic management of psoriasis. It exhibits its efficacy in targeting ROCK2 enzymes within HaCaT cells and has demonstrated beneficial effects in a psoriasis-like mouse model.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | 8-10 weeks | 8-10 weeks | |
| 50 mg | Inquiry | 8-10 weeks | 8-10 weeks |
| Description | ROCK2 inhibitor is a chemical compound associated with the therapeutic management of psoriasis. It exhibits its efficacy in targeting ROCK2 enzymes within HaCaT cells and has demonstrated beneficial effects in a psoriasis-like mouse model. |
| In vitro | ROCK2-IN-7 (2-5$, 24 hours) inhibits the ROCK2/pSTAT3 signaling pathway in HaCaT cells [1]. |
| In vivo | ROCK2-IN-7 administration (20-80 mg/kg, oral, daily for 7 days) reduced key interleukins associated with the IL-23/Th17 axis and important factors involved in keratinocyte proliferation [1]. Concurrently, ROCK2-IN-79 (20-80 mg/kg, oral, daily for 7 days) inhibited systemic immune activation, alleviating inflammation [1]. |
| Molecular Weight | 445.53 |
| Formula | C26H28FN5O |
| Cas No. | 3000541-95-4 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.